Screener
Alignment Healthcare ALHC Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 0.5%+3.5pp | -0%+4.7pp | -0.6%+5.3pp | -1.5%+5.3pp | -3%+4.8pp | |
| Returns | ||||||
| Return on equity | 12.6%+88.4pp | -0.5%+99.2pp | -15.1%+80.1pp | -38.5%+53.1pp | -75.8%+13.1pp | |
| Efficiency | ||||||
| Asset turnover | 3.9×0.0× | 4.3×+0.3× | 4.1×+0.7× | 3.9×+0.9× | 3.9×+1.0× | |
| Liquidity | ||||||
| Current ratio | 1.6×-0.1× | 1.7×-0.2× | 1.6×0.0× | 1.7×0.0× | 1.7×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1.6×-1.4× | 1.8×-1.5× | 2×+0.1× | 2.3×+0.5× | 3×+1.7× | |
| Net debt / EBITDA | -5.8×— | -5.5×— | -9.3×— | -35×— | —— | |
| Per Share | ||||||
| Book value per share | $0.97+73.8% | $0.91+73.0% | $0.77+29.4% | $0.67+3.8% | $0.56-19.4% | |
| Valuation | ||||||
| Market capitalization | $1.69B-49.5% | $3.95B+83.2% | $3.46B+52.8% | $2.79B+86.3% | $3.57B+281% | |
| Price / earnings | 85.5×— | —— | —— | —— | —— | |
| Price / sales | 0.4×-0.5× | 1×+0.2× | 1×0.0× | 0.8×+0.2× | 1.2×+0.7× | |
| Price / book | 7.8×-11.9× | 22×+0.4× | 21.3×+1.6× | 19.8×+7.7× | 33×+25.9× | |
| EV / EBITDA | 18.4×-72.1× | 82.1×— | 99.2×— | 614.8×— | —— |
FAQ
- Where do Alignment Healthcare's ratios come from?
- Every ratio is computed from Alignment Healthcare's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
